3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
221
Carcinoma, Renal Cell
84
Urinary Bladder Neoplasms
65
Breast Neoplasms
36
Carcinoma, Transitional Cell
33
Colorectal Neoplasms
31
Ovarian Neoplasms
29
Kidney Neoplasms
29
Melanoma
27
Carcinoma, Non-Small-Cell Lung
27
Neoplasms
24
Neoplasm Metastasis
24
Sarcoma
22
Non-Muscle Invasive Bladder Neoplasms
19
Endometrial Neoplasms
19
Wilms Tumor
17
Uterine Cervical Neoplasms
17
Lung Neoplasms
17
Triple Negative Breast Neoplasms
15
Stomach Neoplasms
15
Carcinoma, Hepatocellular
15
Adenocarcinoma
15
Squamous Cell Carcinoma of Head and Neck
14
Pancreatic Neoplasms
14
Rhabdomyosarcoma
12
Osteosarcoma
12
Neuroblastoma
12
Glioma
12
Esophageal Neoplasms
12
Metastatic Castration-resistant Prostate Cancer
11
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
Genitourinary
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts